Publications by authors named "David W Covert"

Claim this Profile
A
An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010-2014.
Jordana K Schmier, Carolyn K Hulme-Lowe, David W Covert, Edmund C Lau

Clin Ophthalmol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment costs of cystoid macular edema among patients following cataract surgery.
Jordana K Schmier, David W Covert, Carolyn K Hulme-Lowe, Anmol Mullins, Emmanuel M Mahlis

Clin Ophthalmol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs.
Jordana K Schmier, Carolyn K Hulme-Lowe, David W Covert

Clin Ophthalmol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma.
Jordana K Schmier, David W Covert, Edmund C Lau

Clin Drug Investig· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and costs associated with progression of age-related macular degeneration.
Jordana K Schmier, David W Covert, Edmund C Lau

Am J Ophthalmol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients: a Canadian population-based analysis.
Michael Iskedjian, David W Covert, John H Walker

Patient· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-year treatment costs among new initiators of topical prostaglandin analogs.
Jordana K Schmier, David W Covert, Alan L Robin

Clin Ophthalmol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of respondents with glaucoma and dry eye in a national panel survey.
Jordana K Schmier, David W Covert

Clin Ophthalmol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008.
Jordana K Schmier, David W Covert, Alan L Robin

Curr Med Res Opin· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs.
Jordana K Schmier, Edmund C Lau, David W Covert

Clin Ophthalmol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results.
Jordana K Schmier, David W Covert

Clin Ophthalmol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of visual impairment on service and device use by individuals with diabetic retinopathy.
Jordana K Schmier, David W Covert, G Philip Matthews, Z Nicholas Zakov

Disabil Rehabil· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006.
Jordana K Schmier, David W Covert, Edmund C Lau, Alan L Robin

Arch Ophthalmol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An objective evaluation of eyedrop instillation in patients with glaucoma.
Jennifer L Stone, Alan L Robin, Gary D Novack, David W Covert, Gerald D Cagle

Arch Ophthalmol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-year treatment patterns among new initiators of topical prostaglandin analogs.
Jordana K Schmier, David W Covert, Alan L Robin

Curr Med Res Opin· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicare expenditures associated with diabetes and diabetic retinopathy.
Jordana K Schmier, David W Covert, Edmund C Lau, G Philip Matthews

Retina· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation.
Alan L Robin, Abbot F Clark, David W Covert, Scott Krueger, Michael V W Bergamini

Am J Ophthalmol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective.
Jordana K Schmier, David W Covert, Alan L Robin

Curr Med Res Opin· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
Alan L Robin, Gary D Novack, David W Covert, R Stephens Crockett, Tania S Marcic

Am J Ophthalmol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Medicare costs of endophthalmitis among patients after cataract surgery.
Jordana K Schmier, Michael T Halpern, David W Covert, Edmund C Lau, Alan L Robin

Ophthalmology· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of costs for cystoid macular edema among patients after cataract surgery.
Jordana K Schmier, Michael T Halpern, David W Covert, G Philip Matthews

Retina· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of visual impairment on service and device use by individuals with age-related macular degeneration (AMD).
Jordana K Schmier, Michael T Halpern, David W Covert, Judith Delgado, Sanjay Sharma

Disabil Rehabil· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression.
Jordana K Schmier, Michael T Halpern, David W Covert, Alan L Robin

Curr Med Res Opin· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.
Michael T Halpern, David W Covert, Alan L Robin

Trans Am Ophthalmol Soc· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis